Western Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Western Europe Analysis

Industry Trend Analysis - Sanofi/WRAIR Deal Heightens Argument Around US Investment - JULY 2017

The ongoing debate around the Zika vaccine deal between the US Army and Sanofi is set to continue throughout the R&D process. There is little interest for pharmaceutical companies to spend a large amount of money on developing a novel vaccine and there is risk to these not being profitable. If there are changes in the future licensing deals, due to ongoing controversy, this will...

READ FULL ARTICLE...

Industry Trend Analysis - Generic Competition To Continue To Hurt AstraZeneca Revenues - JUNE 2017

AstraZeneca's shareholders will keep a close eye on the company's management's strategy, the late-stage R&D pipeline and newly launched USD1.1bn cost-cutting plan. While investor focus on company activity has been strong since the decline in sales of the company's top blockbuster drugs - Nexium lost patent protection in the US in February 2015 and Crestor experienced patent expiry in...

READ FULL ARTICLE...